Two Depression Drugs Flop; ECT vs Ketamine; 'Depressive Realism' Squashed

(MedPage Today) -- The investigational drug REL-1017 flopped for patients with major depressive disorder in the phase III RELIANCE III trial, failing to make a significant dent in depression symptoms by day 28, Relmada Therapeutics announced....